Ohalo Genetics
Ohalo is an agricultural biotechnology company developing improved plant varieties using its core technology, Boosted Breeding™, to increase crop yields.
Secondary Market Price
How Ohalo Genetics Measures Up
To help you manage your Ohalo Genetics equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Ohalo Genetics's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Ohalo Genetics Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Ohalo Genetics's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Ohalo Genetics is a company focused on plant breeding and agricultural technology. It is currently developing new breeding systems and plant varieties for crops including potatoes, corn, and berries. The company's primary technology is called Boosted Breeding™, a system designed to pass the entire genome from two parent plants to the offspring. Ohalo also provides a service called True Seed™, which delivers uniform seedlings to growers, and has developed FruitionOne, a self-fertile Nonpareil almond variety. Information regarding the company's founding date, founders, and early history is not publicly detailed.
Looking forward, Ohalo Genetics intends to expand its work into additional crops and develop value-added traits to improve factors like sustainability, taste, and shelf life. A recent development for the company is the launch of the Strawberry Consortium. This collaboration is focused on developing new strawberry varieties with enhanced flavor, which will be brought to market as true seed.
- The Production Board
- Anthemis
- University of Florida Investment Corporation
- Hedosophia
- Co-Founder, David Friedberg
- Co-Founder, Judson Ward
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Ohalo Genetics worth joining?
Evaluating an offer from a private company like Ohalo Genetics requires a close look at its growth potential and your equity compensation package. Tools like Prospect can help you analyze the value of your potential equity and compare it against other opportunities to make an informed decision.
What should I do with my Ohalo Genetics stock?
The best strategy for your Ohalo Genetics stock depends on your personal financial goals, tax situation, and the company's performance. Platforms like Prospect can provide personalized, data-driven strategies for exercising options and selling shares to help you maximize your returns.
Can you sell Ohalo Genetics stock?
Selling stock in a private company like Ohalo Genetics is typically possible through specific events like tender offers or on secondary markets, but it is often subject to company restrictions. If you have an opportunity to sell, tools are available to help you decide how much to sell and which shares are the most tax-optimal.
How can I find the value of my Ohalo Genetics stock?
The value of private stock is typically determined by its 409A valuation, but this may not reflect its true market potential. To get a clearer picture, you can use platforms like Prospect, which use predictive models and secondary market data to forecast your equity's future value.
What is Ohalo Genetics's equity worth?
A private company's valuation is typically set during its most recent funding round, but this figure can be opaque and change quickly. Tools from Prospect can help you understand what your specific equity stake in Ohalo Genetics might be worth by modeling various outcomes based on investor-grade data.
What is Ohalo Genetics's stock ticker symbol?
As a private company, Ohalo Genetics does not have a stock ticker symbol since its shares are not traded on public exchanges like the NYSE or NASDAQ. Ticker symbols are only assigned to companies once they become publicly traded through an Initial Public Offering (IPO).
Can I buy or sell Ohalo Genetics stock?
Buying stock in a private company like Ohalo Genetics is generally limited to employees receiving equity compensation or accredited investors in specific funding rounds. Selling is also restricted, but platforms like Prospect can help employees who hold equity manage their holdings and navigate selling opportunities like tender offers.
What is the criteria to buy or invest in Ohalo Genetics stock?
Investing in a private company is usually restricted to accredited investors and institutions, while employees can acquire stock by exercising their options. If you are an employee with equity, tools from Prospect can help you create a strategy for when and how to exercise your options, rather than focusing on initial investment criteria.
